Form 8-K - Current report:
SEC Accession No. 0001104659-19-070966
Filing Date
2019-12-09
Accepted
2019-12-09 16:12:04
Documents
2
Period of Report
2019-12-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924796d1_8k.htm 8-K 20827
2 EXHIBIT 99.1 tm1924796d1_ex99-1.htm EX-99.1 11351
  Complete submission text file 0001104659-19-070966.txt   33578
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 191275398
SIC: 2836 Biological Products, (No Diagnostic Substances)